The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront ...

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

High DAR Dual-Payload ADC Sutro unveils unique cell-free capabilities Proprietary cell-free platform enables the design of ...

Cambridge’s Camp4 Therapeutics Inc. and Waltham’s Upstream Bio Inc. will both make their debuts on the public markets Friday.

The offering will fund testing of a potential rival to Amgen’s Tezpire and is already the sixth for an immune drug developer ...

Sutro Biopharma (STRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Reni ...

The treatment of metabolic dysfunction-associated steatohepatitis (MASH) has proven challenging, with many compounds failing during development for various reasons. However, with the recent ...

RxDx Assay to identify patients with gastric or GEJ cancer gets CE Mark approval: Basel Friday, October 11, 2024, ...

Four Taiwanese employees of Foxconn, also known as Hon Hai Precision Industry, the primary assembly partner of Apple Inc.

Japanese nationals have become increasingly jittery over traveling to China after several Japanese were targeted in violent attacks.